Who owns Champions Oncology?

Tip: Access positions for across all investors

Analyze quarterly positions in Champions Oncology with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Champions Oncology stock

Who bought or sold Champions Oncology this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Battery Management Corp. 2.4M $14M 0% Mar 2026
 View chart
NEA Management Company 1.7M $9.9M 0% Mar 2026
 View chart
Vanguard Group 335k $2.3M 0% Dec 2025
 View chart
Tocqueville Asset Management 320k $1.8M 0% Mar 2026
 View chart
Vanguard Capital Management 300k $1.7M 100% Mar 2026
 View chart
Morgan Stanley 242k $1.4M 6% Mar 2026
 View chart
Renaissance Technologies 155k $1.1M -7% Dec 2025
 View chart
BlackRock 124k $712k 1% Mar 2026
 View chart
Mink Brook Asset Management 111k $640k 39% Mar 2026
 View chart
Geode Capital Management 77k $444k 2% Mar 2026
 View chart
Northern Trust 46k $319k -1% Dec 2025
 View chart
HighTower Advisors 35k $202k 0% Mar 2026
 View chart
Vanguard Fiduciary Trust 33k $190k 100% Mar 2026
 View chart
State Street Corporation 26k $181k 0% Dec 2025
 View chart
Dimensional Fund Advisors 24k $138k -5% Mar 2026
 View chart
Jane Street 23k $133k -36% Mar 2026
 View chart
Bank of America Corporation 22k $126k 100% Mar 2026
 View chart
Bank of New York Mellon 22k $124k -19% Mar 2026
 View chart
Acadian Asset Management 21k $121k -29% Mar 2026
 View chart
Essex Investment Management 18k $105k 0% Mar 2026
 View chart
Mesirow Financial Investment Management International Equity 16k $91k 53% Mar 2026
 View chart
Cambridge Investment Research Advisors 12k $70k 0% Mar 2026
 View chart
Vanguard Global Advisers 2.1k $12k 100% Mar 2026
 View chart
Capital Advisors 48.00 $0 0% Mar 2026
 View chart
Cassaday & Co Wealth Management 10.00 $58.000000 100% Mar 2026
 View chart
SBI Securities 4.00 $23.000000 0% Mar 2026
 View chart

Who sold out of Champions Oncology?

Fund or Company Name Date Sold Shares Held Valued At
GSA Capital Partners Dec 2025 21k $145k
Susquehanna International Sep 2025 20k $128k
O'shaughnessy Asset Management Dec 2025 13k $90k
Millennium Management Dec 2025 10k $71k
Royal Bank of Canada Sep 2025 6.6k $43k
Whittier Trust Dec 2025 800.00 $5.3k
UBS Group Dec 2025 190.00 $1.3k
Jpmorgan Chase & Co Sep 2025 11.00 $70.999500